Triple-negative breast cancer (TNBC) is characterized by the absence of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2, contributing to its aggressive nature, limited treatment options, and poor prognosis. Here, ERBB2 is linked to triple-negative breast carcinoma.